May 21, 2026 05:14PM
May 6, 2026 07:30AM
Mar 5, 2026 07:00AM
Nov 4, 2025 07:30AM
Aug 6, 2025 07:00AM
Jul 30, 2025 07:31AM
Jul 30, 2025 07:30AM Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products
May 6, 2025 07:30AM
Mar 11, 2025 07:30AM
Jan 2, 2025 08:00AM
Nov 5, 2024 07:30AM
Oct 1, 2024 09:00AM
Aug 6, 2024 07:30AM
May 7, 2024 07:00AM Bioventus Reports First Quarter Financial Results
Mar 12, 2024 07:30AM
Nov 7, 2023 07:00AM
Aug 8, 2023 07:30AM
May 23, 2023 07:30AM
May 16, 2023 04:15PM
May 10, 2023 09:00AM
Mar 31, 2023 07:30AM Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results
Mar 6, 2023 09:00PM
Mar 1, 2023 09:00PM
Feb 24, 2023 09:00PM
Feb 19, 2023 09:00PM
Feb 13, 2023 09:00PM
Nov 21, 2022 05:15PM
Nov 8, 2022 07:30AM Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance
Aug 11, 2022 07:00AM
Aug 3, 2022 07:12AM
Aug 3, 2022 07:00AM
Jul 12, 2022 08:30AM
May 10, 2022 07:00AM
Apr 26, 2022 09:06AM
Apr 26, 2022 09:05AM Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA
Apr 8, 2022 09:25AM
Apr 8, 2022 09:15AM
Apr 4, 2022 07:00AM
Apr 4, 2022 07:00AM
Mar 10, 2022 07:00AM
Mar 1, 2022 07:00AM
Feb 28, 2022 07:02AM Bioventus (BVS) Appoints Mark Singleton as CFO
Feb 28, 2022 07:00AM
Feb 9, 2022 07:35AM
Jan 11, 2022 07:09AM
Jan 11, 2022 07:00AM
Dec 21, 2021 09:25AM
Dec 20, 2021 08:36AM
Dec 20, 2021 08:30AM Bioventus Receives US FDA Clearance for BoneScalpel® Access™
Nov 15, 2021 07:31AM

322,243 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All